SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

9 Months Ended

Sep. 30, 2013

Segment Reporting [Abstract]

Total Revenue By Major Geographic Area

Net sales and profit by reportable segment for the three and nine months ended September 30, 2013 and 2012 are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
	(In thousands)
Segment Net Sales
U.S. Neurosurgery	$	45,114		$	43,269		$	125,877		$	125,776
U.S. Instruments	41,798			41,469			118,737			120,732
U.S. Extremities	33,541			32,961			98,440			91,596
U.S. Spine and Other	46,904			49,188			133,414			142,821
International	45,889			43,197			138,977			135,514
Total revenues	$	213,246		$	210,084		$	615,445		$	616,439
Segment Profit
U.S. Neurosurgery	$	23,080		$	23,201		$	59,770		$	66,247
U.S. Instruments	12,654			11,811			33,172			33,860
U.S. Extremities	14,570			14,996			38,529			37,484
U.S. Spine and Other	(31,437		)	14,771			(5,970		)	42,166
International	14,693			14,550			41,697			45,456
Segment profit	33,560			79,329			167,198			225,213
Amortization	(3,036		)	(4,618)			(9,660)			(13,985)
Corporate and other	(60,138		)	(54,975		)	(179,218		)	(156,004		)
Operating (loss) income	$	(29,614	)	$	19,736		$	(21,680	)	$	55,224

Total revenue by major geographic area consisted of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
	(In thousands)
United States	$	166,555	$	165,930	$	473,740	$	478,087
Europe	21,543		20,351		68,936		66,903
Rest of World	25,148		23,803		72,769		71,449
Total Revenues	$	213,246	$	210,084	$	615,445	$	616,439

Revenue by major product category consisted of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
	(In thousands)
Orthopedics	$	93,331	$	94,186	$	275,025	$	276,033
Neurosurgery	72,639		69,667		204,283		203,499
Instruments	47,276		46,231		136,137		136,907
Total Revenues	$	213,246	$	210,084	$	615,445	$	616,439